Palatin Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTN and other ETFs, options, and stocks.About PTN
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).
CEOCarl Spana
CEOCarl Spana
Employees34
Employees34
HeadquartersCranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded1986
Founded1986
Employees34
Employees34
PTN Key Statistics
Market cap30.01M
Market cap30.01M
Price-Earnings ratio-0.71
Price-Earnings ratio-0.71
Dividend yield—
Dividend yield—
Average volume1.57M
Average volume1.57M
High today$1.95
High today$1.95
Low today$1.84
Low today$1.84
Open price$1.88
Open price$1.88
Volume154.67K
Volume154.67K
52 Week high$5.65
52 Week high$5.65
52 Week low$1.43
52 Week low$1.43